Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCAX | ABCL | CTKB | ||
| Company | Bicara Therapeutics Inc | Abcellera Biologics Inc | Cytek Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.68 | 3.20 | 6.89 | ||
| High | 17.39 | 3.43 | 6.91 | ||
| Low | 15.54 | 3.14 | 6.76 | ||
| Last | 15.59 | 3.31 | 6.79 | ||
| Change | -1.10 | +0.18 | -0.04 | ||
| % Change | -6.59% | +5.75% | -0.59% | ||
| Volume | 431,300 | 4,585,200 | 520,400 | ||
| 20-Day Average Volume | 610,765 | 2,781,255 | 566,760 | ||
| Previous Close | 16.69 | 3.13 | 6.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.10 | 2.93 | 6.51 | ||
| 20-Day Raw Stochastic | 0.70% | 85.19% | 86.21% | ||
| 20-Day Relative Strength | 37.76% | 62.00% | 57.15% | ||
| Weighted Alpha | N/A | -27.80 | -19.47 | ||
| Today's Opinion | N/A | 56% Buy | 88% Buy | ||
| Previous Opinion | N/A | 32% Buy | 88% Buy | ||
| Last Month's Opinion | N/A | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.67% since 12/27/24 | +10.70% since 12/27/24 | +6.26% since 12/27/24 | ||
| Low | 15.54 on 01/06/25 | 2.79 on 12/30/24 | 6.41 on 12/30/24 | ||
| High | 18.22 on 12/30/24 | 3.43 on 01/06/25 | 6.91 on 01/06/25 | ||
| 1-Month | |||||
| %Chg | -26.11% since 12/06/24 | +10.33% since 12/06/24 | +4.95% since 12/06/24 | ||
| Low | 15.54 on 01/06/25 | 2.62 on 12/19/24 | 6.04 on 12/20/24 | ||
| High | 22.67 on 12/09/24 | 3.43 on 01/06/25 | 6.91 on 01/06/25 | ||
| 3-Month | |||||
| %Chg | -38.04% since 10/04/24 | +32.40% since 10/04/24 | +34.19% since 10/04/24 | ||
| Low | 15.54 on 01/06/25 | 2.41 on 10/10/24 | 4.66 on 10/25/24 | ||
| High | 28.09 on 11/06/24 | 3.43 on 01/06/25 | 7.63 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | N/A since 09/13/24 | +23.05% since 07/05/24 | +21.25% since 07/05/24 | ||
| Low | 15.54 on 01/06/25 | 2.34 on 09/10/24 | 4.66 on 10/25/24 | ||
| High | 28.09 on 11/06/24 | 3.60 on 07/17/24 | 7.63 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 908,203 | 924,496 | 879,779 | ||
| Shares Outstanding, K | 54,416 | 295,366 | 128,811 | ||
| Annual Sales | 0 | 38,030,000 | 193,020,000 | ||
| Annual Net Income | -51,985,000 | -146,400,000 | -12,150,000 | ||
| Last Quarter Sales | 0 | 6,510,000 | 51,500,000 | ||
| Last Quarter Net Income | -17,481,000 | -51,110,000 | 940,000 | ||
| 60-Month Beta | N/A | 0.40 | 1.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.60 on 11/12/24 | -0.17 on 11/04/24 | 0.01 on 11/05/24 | ||
| Latest Earnings Date | 02/11/25 | 02/18/25 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||